Picture of Wuhan YZY Biopharma Co logo

2496 Wuhan YZY Biopharma Co Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m+0.39%
3m-12.76%
6m-21.26%
1yrn/a
Volume Change (%)
10d/3m-74.45%
Price vs... (%)
52w High-62.37%
50d MA-1.04%
200d MA-18.56%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-148.13%
Return on Equity-135.22%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Wuhan YZY Biopharma Co EPS forecast chart

Profile Summary

Wuhan YZY Biopharma Co Ltd is a China-based company principally engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The Company's drug products are mainly used in major diseases such as tumor, immunity, inflammation, cardiovascular and infection.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    July 8th, 2010
    Public Since
    September 25th, 2023
    No. of Employees
    123
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    hk flag iconStock Exchange of Hong Kong Limited
    Shares in Issue
    193,849,200

    2496 Share Price Performance

    Upcoming Events for 2496

    Wuhan YZY Biopharma Co Ltd Annual Shareholders Meeting

    Similar to 2496

    Picture of Abbisko Cayman logo

    Abbisko Cayman

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Akeso logo

    Akeso

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Alphamab Oncology logo

    Alphamab Oncology

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Antengene logo

    Antengene

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Ascentage Pharma International logo

    Ascentage Pharma International

    hk flag iconStock Exchange of Hong Kong Limited

    FAQ

    0